Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Ependymoma
NCT00003479Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Jul 1966
- Primary completion
- Oct 2000
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in ependymoma, sponsored by Burzynski Research Institute. Started Jul 1966; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT00003479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003479.